Wearable and digital devices to monitor and treat metabolic diseases.
Journal
Nature metabolism
ISSN: 2522-5812
Titre abrégé: Nat Metab
Pays: Germany
ID NLM: 101736592
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
received:
12
05
2022
accepted:
07
03
2023
medline:
28
4
2023
pubmed:
27
4
2023
entrez:
26
4
2023
Statut:
ppublish
Résumé
Cardiometabolic diseases are a major public-health concern owing to their increasing prevalence worldwide. These diseases are characterized by a high degree of interindividual variability with regards to symptoms, severity, complications and treatment responsiveness. Recent technological advances, and the growing availability of wearable and digital devices, are now making it feasible to profile individuals in ever-increasing depth. Such technologies are able to profile multiple health-related outcomes, including molecular, clinical and lifestyle changes. Nowadays, wearable devices allowing for continuous and longitudinal health screening outside the clinic can be used to monitor health and metabolic status from healthy individuals to patients at different stages of disease. Here we present an overview of the wearable and digital devices that are most relevant for cardiometabolic-disease-related readouts, and how the information collected from such devices could help deepen our understanding of metabolic diseases, improve their diagnosis, identify early disease markers and contribute to individualization of treatment and prevention plans.
Identifiants
pubmed: 37100995
doi: 10.1038/s42255-023-00778-y
pii: 10.1038/s42255-023-00778-y
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
563-571Informations de copyright
© 2023. Springer Nature Limited.
Références
Dagher, L., Shi, H., Zhao, Y. & Marrouche, N. F. Wearables in cardiology: here to stay. Heart Rhythm 17, 889–895 (2020).
pubmed: 32354455
doi: 10.1016/j.hrthm.2020.02.023
González, S. et al. Features and models for human activity recognition. Neurocomputing 167, 52–60 (2015).
doi: 10.1016/j.neucom.2015.01.082
Pannurat, N., Thiemjarus, S. & Nantajeewarawat, E. A hybrid temporal reasoning framework for fall monitoring. IEEE Sens. J. 17, 1749–1759 (2017).
doi: 10.1109/JSEN.2017.2649542
Brown, S. A. et al. Overnight closed-loop control improves glycemic control in a multicenter study of adults with type 1 diabetes. J. Clin. Endocrinol. Metab. 102, 3674–3682 (2017).
pubmed: 28666360
pmcid: 5630248
doi: 10.1210/jc.2017-00556
Dudde, R., Vering, T., Piechotta, G. & Hintsche, R. Computer-aided continuous drug infusion: setup and test of a mobile closed-loop system for the continuous automated infusion of insulin. IEEE Trans. Inf. Technol. Biomed. 10, 395–402 (2006).
pubmed: 16617628
doi: 10.1109/TITB.2006.864477
Turakhia, M. P. et al. Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: The Apple Heart Study. Am. Heart J. 207, 66–75 (2019).
pubmed: 30392584
doi: 10.1016/j.ahj.2018.09.002
Shashikumar, S. P., Shah, A. J., Li, Q., Clifford, G. D. & Nemati, S. A deep learning approach to monitoring and detecting atrial fibrillation using wearable technology. in 2017 IEEE EMBS International Conference on Biomedical & Health Informatics (BHI) 141–144 (IEEE, 2017).
Nemati, S. et al. Monitoring and detecting atrial fibrillation using wearable technology. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2016, 3394–3397 (2016).
Hall, H. et al. Glucotypes reveal new patterns of glucose dysregulation. PLoS Biol. 16, e2005143 (2018).
pubmed: 30040822
pmcid: 6057684
doi: 10.1371/journal.pbio.2005143
Tao, R. et al. Multilevel clustering approach driven by continuous glucose monitoring data for further classification of type 2 diabetes. BMJ Open Diabetes Res. Care 9, e001869 (2021).
pubmed: 33627315
pmcid: 7908294
doi: 10.1136/bmjdrc-2020-001869
Lu, L. et al. Wearable health devices in health care: narrative systematic review. JMIR Mhealth Uhealth 8, e18907 (2020).
pubmed: 33164904
pmcid: 7683248
doi: 10.2196/18907
Bayoumy, K. et al. Smart wearable devices in cardiovascular care: where we are and how to move forward. Nat. Rev. Cardiol. 18, 581–599 (2021).
pubmed: 33664502
pmcid: 7931503
doi: 10.1038/s41569-021-00522-7
Costello, K. R. & Schones, D. E. Chromatin modifications in metabolic disease: potential mediators of long-term disease risk. Wiley Interdiscip. Rev. Syst. Biol. Med. 10, e1416 (2018).
pubmed: 29369528
pmcid: 6002879
doi: 10.1002/wsbm.1416
Guariguata, L., Whiting, D., Weil, C. & Unwin, N. The international diabetes federation diabetes atlas methodology for estimating global and national prevalence of diabetes in adults. Diabetes Res. Clin. Pract. 94, 322–332 (2011).
pubmed: 22100977
doi: 10.1016/j.diabres.2011.10.040
Lin, C.-F., Chang, Y.-H., Chien, S.-C., Lin, Y.-H. & Yeh, H.-Y. Epidemiology of dyslipidemia in the Asia Pacific region. Int. J. Gerontol. 12, 2–6 (2018).
doi: 10.1016/j.ijge.2018.02.010
Hirode, G. & Wong, R. J. Trends in the prevalence of metabolic syndrome in the United States, 2011–2016. JAMA 323, 2526–2528 (2020).
pubmed: 32573660
pmcid: 7312413
doi: 10.1001/jama.2020.4501
Bruce, K. D. & Byrne, C. D. The metabolic syndrome: common origins of a multifactorial disorder. Postgrad. Med. J. 85, 614–621 (2009).
pubmed: 19892897
doi: 10.1136/pgmj.2008.078014
Lann, D. & LeRoith, D. Insulin resistance as the underlying cause for the metabolic syndrome. Med. Clin. North Am. 91, 1063–77 (2007).
pubmed: 17964909
doi: 10.1016/j.mcna.2007.06.012
Roberts, C. K., Hevener, A. L. & Barnard, R. J. Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr. Physiol. 3, 1–58 (2013).
pubmed: 23720280
pmcid: 4129661
Rodbard, D. Continuous glucose monitoring: a review of successes, challenges, and opportunities. Diabetes Technol. Ther. 18, S3–S13 (2016).
pubmed: 26784127
doi: 10.1089/dia.2015.0417
Wang, Y., Xue, H., Huang, Y., Huang, L. & Zhang, D. A systematic review of application and effectiveness of mHealth interventions for obesity and diabetes treatment and self-management. Adv. Nutr. 8, 449–462 (2017).
pubmed: 28507010
pmcid: 5421120
doi: 10.3945/an.116.014100
Dunn, J. et al. Wearable sensors enable personalized predictions of clinical laboratory measurements. Nat. Med. 27, 1105–1112 (2021).
pubmed: 34031607
pmcid: 8293303
doi: 10.1038/s41591-021-01339-0
Selvin, E., Crainiceanu, C. M., Brancati, F. L. & Coresh, J. Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch. Intern. Med. 167, 1545–1551 (2007).
pubmed: 17646610
doi: 10.1001/archinte.167.14.1545
Danne, T. et al. International consensus on use of continuous glucose monitoring. Diabetes Care 40, 1631–1640 (2017).
pubmed: 29162583
pmcid: 6467165
doi: 10.2337/dc17-1600
Lee, S. et al. Predictions of diabetes complications and mortality using HbA1c variability: a 10-year observational cohort study. Acta Diabetol. 58, 171–180 (2021).
pubmed: 32939583
doi: 10.1007/s00592-020-01605-6
Chehregosha, H., Khamseh, M. E., Malek, M., Hosseinpanah, F. & Ismail-Beigi, F. A view beyond HbA1c: role of continuous glucose monitoring. Diabetes Ther. 10, 853–863 (2019).
pubmed: 31037553
pmcid: 6531520
doi: 10.1007/s13300-019-0619-1
Rohlfing, C., Hanson, S. & Little, R. R. Measurement of hemoglobin A1c in patients with sickle cell trait. JAMA 317, 2237 (2017).
pubmed: 28586882
doi: 10.1001/jama.2017.4643
Vigersky, R. A. The benefits, limitations, and cost-effectiveness of advanced technologies in the management of patients with diabetes mellitus. J. Diabetes Sci. Technol. 9, 320–330 (2015).
pubmed: 25555391
pmcid: 4604582
doi: 10.1177/1932296814565661
Dobreanu, D. et al. Current practice for diagnosis and management of silent atrial fibrillation: results of the European Heart Rhythm Association survey. Europace 15, 1223–1225 (2013).
pubmed: 23878150
doi: 10.1093/europace/eut227
Dagres, N. et al. Influence of the duration of Holter monitoring on the detection of arrhythmia recurrences after catheter ablation of atrial fibrillation. Int. J. Cardiol. 139, 305–306 (2010).
pubmed: 18990460
doi: 10.1016/j.ijcard.2008.10.004
Bouzid, Z., Al-Zaiti, S. S., Bond, R. & Sejdić, E. Remote and wearable ECG devices with diagnostic abilities in adults: a state-of-the-science scoping review. Heart Rhythm 19, 1192–1201 (2022).
pubmed: 35276320
doi: 10.1016/j.hrthm.2022.02.030
Ginsberg, H. N. Insulin resistance and cardiovascular disease. J. Clin. Invest. 106, 453–458 (2000).
pubmed: 10953019
pmcid: 380256
doi: 10.1172/JCI10762
Paneni, F., Costantino, S. & Cosentino, F. Insulin resistance, diabetes, and cardiovascular risk. Curr. Atheroscler. Rep. 16, 419 (2014).
pubmed: 24781596
doi: 10.1007/s11883-014-0419-z
Wilcox, G. Insulin and insulin resistance. Clin. Biochem. Rev. 26, 19–39 (2005).
pubmed: 16278749
pmcid: 1204764
Zeevi, D. et al. Personalized nutrition by prediction of glycemic responses. Cell 163, 1079–1094 (2015).
pubmed: 26590418
doi: 10.1016/j.cell.2015.11.001
Wyatt, P. et al. Postprandial glycaemic dips predict appetite and energy intake in healthy individuals. Nat. Metab. 3, 523–529 (2021).
pubmed: 33846643
pmcid: 7610681
doi: 10.1038/s42255-021-00383-x
Cosson, E. et al. Multicentre, randomised, controlled study of the impact of continuous sub-cutaneous glucose monitoring (GlucoDay) on glycaemic control in type 1 and type 2 diabetes patients. Diabetes Metab. 35, 312–318 (2009).
pubmed: 19560388
doi: 10.1016/j.diabet.2009.02.006
Galindo, R. J. & Aleppo, G. Continuous glucose monitoring: the achievement of 100 years of innovation in diabetes technology. Diabetes Res. Clin. Pract. 170, 108502 (2020).
pubmed: 33065179
pmcid: 7736459
doi: 10.1016/j.diabres.2020.108502
Kim, S., Malik, J., Seo, J. M., Cho, Y. M. & Bien, F. Subcutaneously implantable electromagnetic biosensor system for continuous glucose monitoring. Sci. Rep. 12, 17395 (2022).
pubmed: 36253418
pmcid: 9576697
doi: 10.1038/s41598-022-22128-w
Xu, J., Yan, Z. & Liu, Q. Smartphone-based electrochemical systems for glucose monitoring in biofluids: a review. Sensors 22, 5670 (2022).
pubmed: 35957227
pmcid: 9371187
doi: 10.3390/s22155670
Lee, I., Wakako, T., Ikebukuro, K. & Sode, K. In vitro continuous 3 months operation of direct electron transfer type open circuit potential based glucose sensor: heralding the next CGM sensor. J. Diabetes Sci. Technol. 16, 1107–1113 (2022).
pubmed: 35466718
pmcid: 9445357
doi: 10.1177/19322968221092449
Kokkinos, P. Physical activity, health benefits, and mortality risk. ISRN Cardiol. 2012, 718789 (2012).
pubmed: 23198160
pmcid: 3501820
doi: 10.5402/2012/718789
Rhodes, R. E., Janssen, I., Bredin, S. S. D., Warburton, D. E. R. & Bauman, A. Physical activity: health impact, prevalence, correlates and interventions. Psychol. Health 32, 942–975 (2017).
pubmed: 28554222
doi: 10.1080/08870446.2017.1325486
Lakka, T. A. & Laaksonen, D. E. Physical activity in prevention and treatment of the metabolic syndrome. Appl. Physiol. Nutr. Metab. 32, 76–88 (2007).
pubmed: 17332786
doi: 10.1139/h06-113
Degroote, L., De Bourdeaudhuij, I., Verloigne, M., Poppe, L. & Crombez, G. The accuracy of smart devices for measuring physical activity in daily life: validation study. JMIR Mhealth Uhealth 6, e10972 (2018).
pubmed: 30545810
pmcid: 6315254
doi: 10.2196/10972
Case, M. A., Burwick, H. A., Volpp, K. G. & Patel, M. S. Accuracy of smartphone applications and wearable devices for tracking physical activity data. JAMA 313, 625–626 (2015).
pubmed: 25668268
doi: 10.1001/jama.2014.17841
Paluch, A. E. et al. Steps per day and all-cause mortality in middle-aged adults in the coronary artery risk development in young adults study. JAMA Netw. Open 4, e2124516 (2021).
pubmed: 34477847
pmcid: 8417757
doi: 10.1001/jamanetworkopen.2021.24516
Althoff, T. et al. Large-scale physical activity data reveal worldwide activity inequality. Nature 547, 336–339 (2017).
pubmed: 28693034
pmcid: 5774986
doi: 10.1038/nature23018
Althoff, T., Nilforoshan, H., Hua, J. & Leskovec, J. Large-scale diet tracking data reveal disparate associations between food environment and diet. Nat. Commun. 13, 267 (2022).
pubmed: 35042849
pmcid: 8766578
doi: 10.1038/s41467-021-27522-y
Stephens, J. D., Yager, A. M. & Allen, J. Smartphone technology and text messaging for weight loss in young adults: a randomized controlled trial. J. Cardiovasc. Nurs. 32, 39–46 (2017).
pubmed: 26646593
pmcid: 4896848
doi: 10.1097/JCN.0000000000000307
Painter, S. L. et al. What matters in weight loss? An in-depth analysis of self-monitoring. J. Med. Internet Res. 19, e160 (2017).
pubmed: 28500022
pmcid: 5446667
doi: 10.2196/jmir.7457
Marrone, G. et al. Vegan diet health benefits in metabolic syndrome. Nutrients 13, 817 (2021).
pubmed: 33801269
pmcid: 7999488
doi: 10.3390/nu13030817
Giugliano, D., Ceriello, A. & Esposito, K. The effects of diet on inflammation. J. Am. Coll. Cardiol. 48, 677–685 (2006).
pubmed: 16904534
doi: 10.1016/j.jacc.2006.03.052
Berry, S. et al. Personalised REsponses to DIetary Composition Trial (PREDICT): an intervention study to determine inter-individual differences in postprandial response to foods. Protocol Exchange https://doi.org/10.21203/rs.2.20798/v1 (2020).
Ben-Yacov, O. et al. Personalized postprandial glucose response-targeting diet versus mediterranean diet for glycemic control in prediabetes. Diabetes Care 44, 1980–1991 (2021).
pubmed: 34301736
doi: 10.2337/dc21-0162
Ipjian, M. L. & Johnston, C. S. Smartphone technology facilitates dietary change in healthy adults. Nutrition 33, 343–347 (2017).
pubmed: 27742102
doi: 10.1016/j.nut.2016.08.003
Kwon, B. C. et al. Improving heart disease risk through quality-focused diet logging: pre-post study of a diet quality tracking app. JMIR Mhealth Uhealth 8, e21733 (2020).
pubmed: 33355537
pmcid: 7787891
doi: 10.2196/21733
Peos, J. J., Helms, E. R., Fournier, P. A. & Sainsbury, A. Continuous versus intermittent moderate energy restriction for increased fat mass loss and fat free mass retention in adult athletes: protocol for a randomised controlled trial-the ICECAP trial (intermittent versus continuous energy restriction compared in an athlete population). BMJ Open Sport Exerc. Med. 4, e000423 (2018).
pubmed: 30364484
pmcid: 6196972
doi: 10.1136/bmjsem-2018-000423
Kipnis, V., Carroll, R. J., Freedman, L. S. & Li, L. Implications of a new dietary measurement error model for estimation of relative risk: application to four calibration studies. Am. J. Epidemiol. 150, 642–651 (1999).
pubmed: 10490004
doi: 10.1093/oxfordjournals.aje.a010063
Prentice, R. L. Measurement error and results from analytic epidemiology: dietary fat and breast cancer. J. Natl Cancer Inst. 88, 1738–1747 (1996).
pubmed: 8944004
doi: 10.1093/jnci/88.23.1738
Kaaks, R. & Riboli, E. Validation and calibration of dietary intake measurements in the EPIC project: methodological considerations. European Prospective Investigation into Cancer and Nutrition. Int. J. Epidemiol. 26, S15–S25 (1997).
pubmed: 9126530
doi: 10.1093/ije/26.suppl_1.S15
Ancoli-Israel, S. in Understanding Sleep: The Evaluation and Treatment of Sleep Disorders. (eds. Pressman, M. R. & Orr, W. C.) 177–191 (American Psychological Association, 1997).
Park, K. S. & Choi, S. H. Smart technologies toward sleep monitoring at home. Biomed. Eng. Lett. 9, 73–85 (2019).
pubmed: 30956881
pmcid: 6431329
doi: 10.1007/s13534-018-0091-2
Wolk, R. & Somers, V. K. Sleep and the metabolic syndrome. Exp. Physiol. 92, 67–78 (2007).
pubmed: 17085678
doi: 10.1113/expphysiol.2006.033787
Vgontzas, A. N., Bixler, E. O. & Chrousos, G. P. Sleep apnea is a manifestation of the metabolic syndrome. Sleep. Med. Rev. 9, 211–224 (2005).
pubmed: 15893251
doi: 10.1016/j.smrv.2005.01.006
Hoevenaar-Blom, M. P., Spijkerman, A. M. W., Kromhout, D., van den Berg, J. F. & Verschuren, W. M. M. Sleep duration and sleep quality in relation to 12-year cardiovascular disease incidence: the MORGEN study. Sleep 34, 1487–1492 (2011).
pubmed: 22043119
pmcid: 3198203
doi: 10.5665/sleep.1382
Newman, A. B. et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am. J. Epidemiol. 154, 50–59 (2001).
pubmed: 11434366
doi: 10.1093/aje/154.1.50
Colilla, S. et al. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am. J. Cardiol. 112, 1142–1147 (2013).
pubmed: 23831166
doi: 10.1016/j.amjcard.2013.05.063
Perez, M. V. et al. Large-scale assessment of a smartwatch to identify atrial fibrillation. N. Engl. J. Med. 381, 1909–1917 (2019).
pubmed: 31722151
pmcid: 8112605
doi: 10.1056/NEJMoa1901183
Allen, J. Photoplethysmography and its application in clinical physiological measurement. Physiol. Meas. 28, R1–R39 (2007).
pubmed: 17322588
doi: 10.1088/0967-3334/28/3/R01
Ilea, A. et al. Saliva, a magic biofluid available for multilevel assessment and a mirror of general health-a systematic review. Biosensors 9, 27 (2019).
pubmed: 30769890
pmcid: 6468816
doi: 10.3390/bios9010027
Alexeev, V. L., Das, S., Finegold, D. N. & Asher, S. A. Photonic crystal glucose-sensing material for noninvasive monitoring of glucose in tear fluid. Clin. Chem. 50, 2353–2360 (2004).
pubmed: 15459093
doi: 10.1373/clinchem.2004.039701
Bandodkar, A. J., Jeang, W. J., Ghaffari, R. & Rogers, J. A. Wearable sensors for biochemical sweat analysis. Annu Rev. Anal. Chem. 12, 1–22 (2019).
doi: 10.1146/annurev-anchem-061318-114910
Li, G. & Wen, D. Wearable biochemical sensors for human health monitoring: sensing materials and manufacturing technologies. J. Mater. Chem. B Mater. Biol. Med. 8, 3423–3436 (2020).
pubmed: 32022089
doi: 10.1039/C9TB02474C
Gordon, R. S., Thompson, R. H., Muenzer, J. & Thrasher, D. Sweat lactate in man is derived from blood glucose. J. Appl. Physiol. 31, 713–716 (1971).
pubmed: 5117186
doi: 10.1152/jappl.1971.31.5.713
Vinoth, R., Nakagawa, T., Mathiyarasu, J. & Mohan, A. M. V. Fully printed wearable microfluidic devices for high-throughput sweat sampling and multiplexed electrochemical analysis. ACS Sens. 6, 1174–1186 (2021).
pubmed: 33517662
doi: 10.1021/acssensors.0c02446
Sharma, A., Badea, M., Tiwari, S. & Marty, J. L. Wearable biosensors: an alternative and practical approach in healthcare and disease monitoring. Molecules 26, 748 (2021).
pubmed: 33535493
pmcid: 7867046
doi: 10.3390/molecules26030748
Shilo, S. et al. 10K: a large-scale prospective longitudinal study in Israel. Eur. J. Epidemiol. 36, 1187–1194 (2021).
pubmed: 33993378
doi: 10.1007/s10654-021-00753-5
Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203–209 (2018).
pubmed: 30305743
pmcid: 6786975
doi: 10.1038/s41586-018-0579-z
The All of Us Research Program Investigators. The “All of Us” Research Program. N. Engl. J. Med. 381, 668–676 (2019).
pmcid: 8291101
doi: 10.1056/NEJMsr1809937
Scholtens, S. et al. Cohort profile: LifeLines, a three-generation cohort study and biobank. Int. J. Epidemiol. 44, 1172–1180 (2015).
pubmed: 25502107
doi: 10.1093/ije/dyu229
Li, X. et al. Digital health: tracking physiomes and activity using wearable biosensors reveals useful health-related information. PLoS Biol. 15, e2001402 (2017).
pubmed: 28081144
pmcid: 5230763
doi: 10.1371/journal.pbio.2001402
Wyatt, K. D., Poole, L. R., Mullan, A. F., Kopecky, S. L. & Heaton, H. A. Clinical evaluation and diagnostic yield following evaluation of abnormal pulse detected using Apple Watch. J. Am. Med. Inform. Assoc. 27, 1359–1363 (2020).
pubmed: 32979046
pmcid: 7526465
doi: 10.1093/jamia/ocaa137
Phan, D. T. et al. A flexible, wearable, and wireless biosensor patch with internet of medical things applications. Biosensors 12, 139 (2022).
pubmed: 35323409
pmcid: 8945966
doi: 10.3390/bios12030139
Alavi, A. et al. Real-time alerting system for COVID-19 and other stress events using wearable data. Nat. Med. 28, 175–184 (2022).
pubmed: 34845389
doi: 10.1038/s41591-021-01593-2
Adhikari, S. & Stark, D. E. Video-based eye tracking for neuropsychiatric assessment. Ann. N. Y. Acad. Sci. 1387, 145–152 (2017).
pubmed: 28122120
doi: 10.1111/nyas.13305
Powers, R. et al. Smartwatch inertial sensors continuously monitor real-world motor fluctuations in Parkinson’s disease. Sci. Transl. Med. 13, eabd7865 (2021).
pubmed: 33536284
doi: 10.1126/scitranslmed.abd7865
Kankanhalli, A., Shin, J. & Oh, H. Mobile-Based interventions for dietary behavior change and health outcomes: scoping review. JMIR Mhealth Uhealth 7, e11312 (2019).
pubmed: 30664461
pmcid: 6360385
doi: 10.2196/11312
Tate, A. R. & Rao, G. H. R. Activity trackers, wearables, noninvasive technologies for early detection, and management of cardiometabolic risks. Int. J. Biomed. 10, 189–197 (2020).
doi: 10.21103/Article10(3)_RA2
Attia, Z. I. et al. Age and sex estimation using artificial intelligence from standard 12-lead ECGs. Circ. Arrhythm. Electrophysiol. 12, e007284 (2019).
pubmed: 31450977
pmcid: 7661045
doi: 10.1161/CIRCEP.119.007284